Nigerian healthcare companies listed on the Nigerian Exchange experienced substantial growth in 2025, with their cumulative market capitalization reaching N466.73 billion by the end of the year. This represents a significant 220.9% increase compared to the N145.4 billion recorded in 2024, indicating a strong surge in value on the exchange.

Collectively, these companies constituted 0.47% of the total Nigerian Exchange market, which was valued at N99.38 trillion as tracked by the All-Share Index. The exceptional performance of these companies, particularly the pharmaceutical firms, fueled this impressive growth. In 2025, four pharmaceutical firms delivered returns exceeding 100%, ending the year with significant gains.

One major factor contributing to this robust performance appears to be increased sales of pharmaceutical products, which translated into healthier profits for companies reporting nine-month or full-year results in 2025.

Below are details on one of the listed health companies on the NGX, covering pharmaceuticals and healthcare services, based on their market capitalization on the last trading day of 2025.

Pharma-Deko Plc ranks ninth with a market capitalization of N396.7 million as of the last trading day of 2025.

Compared to 2024, when its market cap was also N396.7 million, this reflects no growth, as the share price remained stalled throughout 2025. Since then, its shares have remained frozen at N1.83 per share, which, when multiplied by the 216.8 million shares outstanding, results in the current market capitalization of N396.7 million.